Soumen Khatua, M.B.B.S., M.D.

Soumen Khatua, M.D., is a Senior Associate Consultant and a pediatric Neuro-Oncologist at the Mayo Clinic Rochester. His clinical roles and research focus are on developing a portfolio of clinical trials at Mayo for newly diagnosed and recurrent pediatric brain tumors.

His areas of expertise and interest include:

  • Tumors of the brain and spine in children
  • Developing immunotherapeutic strategies including intracerebral infusion of Natural Killer Cells and radioimmunotherapy for recurrent brain tumors in children
  • Identifying new neuroimaging modalities including radiomics and radiogenomics for pediatric brain tumors which could predict upfront response and distinguish true from pseudo progression

In addition to his clinical expertise, he has been involved in mentoring many residents, fellows and junior faculties in other institutions, to provide career guidance and developing their pediatric brain tumor program. He has been an invited speaker and a visiting professor in many academic centers nationally and internationally.

His clinical interests are designing novel clinical trials using targeted chemotherapy in high-grade glioma including the diffuse midline glioma and developing immunotherapeutic strategies for relapsed/refractory brain tumors in children, was the Principal Investigator of the first in human Phase 1 trial in children, using autologous NK cell infusions into the ventricles of children with recurrent posterior fossa malignant brain tumors, which demonstrated safety. We plan to develop the second phase of the trial in a wider group of recurrent pediatric brain tumors.

  1. 2009
    Clinical FellowshipPediatric Neuro-Oncology, Children's Hospital
  2. 2003
    Clinical FellowshipPediatric Hematology/Oncology, Children's National Medical Center
  3. 2000
    Clinical ResidencyDriscoll Children's Hospital
  4. 1988
    Clinical FellowshipWestminster's Children Hospital
  5. 1987
    Clinical FellowshipUniversity of Illinois
  6. 1986
    Post Doctoral Fellowship - PediatricsCalcutta Medical College
  7. 1983
    Clinical ResidencyCalcutta Medical College
  8. 1983
    InternCalcutta Medical College
  9. 1982
    MBBS - MedicineCalcutta Medical College

Certifications

  1. 2006
    Pediatric Hematology-OncologyAmerican Board of Pediatrics
  2. 2000
    PediatricsAmerican Board of Pediatrics

Awards and honors

  1. 2020
    Academic ExcellencePediatric Society Meeting
  2. 2016
    Best in Category AwardSociety of Pediatric Neuro Oncology
  3. 2016
    Best in Category Award for the Early Phase Clinical TrialInternational Society of Pediatric Neuro Oncology
  4. 2015
    Teaching Award, Department of PediatricsThe University of Texas MD Anderson Cancer Center
  5. 2014
    Teaching Attending of the Year Award, Department of PediatricsThe University of Texas MD Anderson Cancer Center
  6. 2013
    Apple Card Award/Health Education WeekThe University of Texas MD Anderson Cancer Center
  7. 2010
    Hyundai Hope GrantPrimary Children's Medical Center
  8. 2006
    Physician Recognition AwardAmerican Medical Association
  9. 2006
    Strathmore's Who's Who in Medicine and Healthcare
  10. 2005
    FellowshipAmerican Academy of Pediatrics
  11. 2005
    Physician Recognition AwardAmerican Medical Association
  12. 2003
    Physician Recognition AwardAmerican Medical Association
  13. 2003
    Scientific and academic achievement for the superior presentation of the scientific discovery ' Overexpression of the EGFR/FKBP12/HIF2 Alpha- a Novel Pathway Identified in Childhood Astrocytomas by Angiogenesis Gene Profiling'Seventeenth Annual Advances in Pediatrics Educational and Scientific Forum
  14. 2003
    Educational and Scientific Forum
  15. 2002
    Physician Recognition AwardAmerican Medical Association
  16. 2001
    Physician Recognition AwardAmerican Medical Association
  17. 2000
    Physician Recognition AwardAmerican Medical Association

Professional memberships

  1. 2022 - present
    Executive Team MemberCentral Nervous System- 3 Site
  2. 2022 - present
    MemberMayo Clinic Cancer Center Disease Group Leadership
  3. 2021 - present
    Co-Chair of ResearchPediatric Hematology/Oncology (Disease Specialty Group)
  4. 2021 - present
    MemberSociety of Immunotherapy Consortium
  5. 2021 - present
    Secondary MembershipExperimental Therapeutics Program
  6. 2021 - present
    Full MemberMayo Clinic Cancer Center
  7. 2021 - present
    Primary MemberNeuro-Oncology Program
  8. 2021 - present
    DirectorPediatric Neuro-Oncology
  9. 2021
    Grant ReviewerNeurofibromatosis Research Program of the Congressionally Directed Medical Research Program, United States Department of Defense
  10. 2020 - 2021
    Virtual Team MemberCOVID Virtual Task Force, Department of Pediatrics, The University of Texas MD Anderson Cancer Center
  11. 2020
    ReviewerSociety of Neuro-Oncology (SNO)
  12. 2020 - present
    MemberOZM-077 Phase I/Ib trial of combined epigenetic therapy with 5'azacytidine and carboplatin for recurrent/refractory pediatric brain and solid tumors (Hospital for Sick Children, Toronto), Data Safety Monitoring Committee (DSMC)
  13. 2020 - present
    MemberPhase I Clinical Trials, The University of Texas MD Anderson Cancer Center, Data Safety Monitoring Committee (DSMC)
  14. 2019 - 2021
    Executive committee memberBrain Tumor Center (BTC), The University of Texas MD Anderson Cancer Center
  15. 2019 - 2021
    MemberTraining in Brain Tumor Research Seminars, Brain Tumor Center (BTC), The University of Texas MD Anderson Cancer Center
  16. 2019 - 2021
    MemberEducation Committee, Faculty Senate, The University of Texas MD Anderson Cancer Center
  17. 2019 - 2021
    MemberEHR Officers, Department of Pediatrics, The University of Texas MD Anderson Cancer Center
  18. 2019
    MemberWW Sutow Visiting Lecturer Selection Committee, The University of Texas MD Anderson Cancer Center
  19. 2019
    Scientific Committee and Program ChairSociety of Neuro-Oncology, Pediatric Neuro-Oncology Basic and Translational Research Conference, The University of Texas MD Anderson Cancer Center
  20. 2019
    ReviewerSociety of Neuro-Oncology (SNO)
  21. 2019
    MemberSociety of Neuro-Oncology (SNO)
  22. 2019
    MemberMedical Advisory Board, Chance For Life Foundation
  23. 2019
    Grant ReviewerNeurofibromatosis Research Program of the Congressionally Directed Medical Research Program, United States Department of Defense
  24. 2019
    MemberGrant Reviewer, Chance for Life, Pediatric Oncology
  25. 2018 - 2021
    MemberFaculty Senate, The University of Texas MD Anderson Cancer Center
  26. 2018 - 2021
    OfficerEHR Officer, Department of Pediatrics, The University of Texas MD Anderson Cancer Center
  27. 2018 - 2021
    MemberPediatric Hematology/Oncology Fellowship Program Evaluation Committee, The University of Texas MD Anderson Cancer Center
  28. 2018
    MemberThe Samuel J. Hassenbusch, MD, PhD, PRS Leadership & Institutional Service Award 2018 Nominees, The University of Texas MD Anderson Cancer Center
  29. 2018
    MemberInstitutional Search Committee for Chair of Neuro-Oncology, The University of Texas MD Anderson Cancer Center
  30. 2018
    MemberWW Sutow Visiting Lecturer Selection Committee, The University of Texas MD Anderson Cancer Center
  31. 2018
    Scientific Committee and Program ChairPediatric Neuro-Oncology Session, Society of Neuro-Oncology (SNO)
  32. 2018
    ReviewerSociety of Neuro-Oncology (SNO)
  33. 2018
    Grant ReviewerNeurofibromatosis Research Program of the Congressionally Directed Medical Research Program, United States Department of Defense
  34. 2018
    MemberGrant Reviewer Quest for Cure Research Award, Brain Tumor Charity
  35. 2018
    MemberKIKA Grant Reviewer, Stichting Kinderen Kankervrij' (Foundation Children Cancer free) or 'KiKa, KiKa, Netherlands
  36. 2018
    Leading Committee MemberAdapted Therapy Regimen (ATR), International Society of Pediatric Oncology
  37. 2018
    Leading Committee MemberAdapted Therapy Regimen (ATR), International Society of Pediatric Oncology
  38. 2018 - present
    External ReviewerData Safety Monitoring Board, Novartis Pharmaceuticals
  39. 2018 - present
    MemberInternational Society of Paediatric Oncology
  40. 2018 - present
    PODC MemberAdapted Therapy Regimen (ATR), International Society of Pediatric Oncology
  41. 2017 - 2021
    MemberInstitutional PRS Clinical Revenue Cycle Committee, The University of Texas MD Anderson Cancer Center
  42. 2017 - 2021
    Team MemberClinical Trials, Department of Pediatrics, The University of Texas MD Anderson Cancer Center
  43. 2017 - 2021
    Co-LeaderNeural Tumor Team, Department of Pediatrics, The University of Texas MD Anderson Cancer Center
  44. 2017 - 2021
    Team MemberImmunotherapy, Department of Pediatrics, The University of Texas MD Anderson Cancer Center
  45. 2017 - 2021
    Team MemberNeuroimaging, Department of Pediatrics, The University of Texas MD Anderson Cancer Center
  46. 2017 - 2018
    Interview PanelFellowship Program in Pediatric Hematology, Department of Pediatrics, The University of Texas MD Anderson Cancer Center
  47. 2017
    MemberWW Sutow Visiting Lecturer Selection Committee, The University of Texas MD Anderson Cancer Center
  48. 2017
    ChairNeuroscience Update in Pediatric Neuro-Oncology Symposium, The University of Texas MD Anderson Cancer Center
  49. 2017
    Co-ChairPediatric Neuro-Oncology Update, Global Academic Program (GAP), The University of Texas MD Anderson Cancer Center
  50. 2017
    Co-Chair of Conference/SymposiaPediatric Neuro-Oncology Session, Society of Neuro-Oncology (SNO)
  51. 2017
    Co-Chair of Conference/SymposiaFifth International CNS Germ Cell Tumor Conference, Germinoma of the Central Nervous System
  52. 2017
    Chair of Conference/SymposiaPediatric Neuro-Oncology Symposium, The University of Texas MD Anderson Cancer Center
  53. 2017
    Co-Chair of Conference/SymposiaPediatric Neuro-Oncology Update, Global Academic Program (GAP), The University of Texas MD Anderson Cancer Center
  54. 2017
    Scientific Committee and Program ChairPediatric Neuro-Oncology Session, Society of Neuro-Oncology (SNO)
  55. 2017
    MemberSociety of Neuro-Oncology (SNO)
  56. 2017
    ReviewerSociety of Neuro-Oncology (SNO)
  57. 2017
    Grant ReviewerExternal Peer Review Committee, Clinical Biomarkers Grant, Brain Tumor Charity
  58. 2017 - present
    External Reviewer of High- Risk Oncology TrialsNationwide Children’s Hospital Data Safety Monitoring Board
  59. 2017 - present
    MemberAmerican Association of Cancer Research
  60. 2016 - 2017
    Vice ChairGrand Rounds, Department of Pediatrics, The University of Texas MD Anderson Cancer Center
  61. 2016
    MemberKIKA Grant Reviewer, Stichting Kinderen Kankervrij' (Foundation Children Cancer free) or 'KiKa, KiKa, Netherlands
  62. 2015 - 2021
    MemberInstitutional Clinical Research Advisory Committee, The University of Texas MD Anderson Cancer Center
  63. 2015 - 2017
    MemberPRS Budget & Finance Committee, The University of Texas MD Anderson Cancer Center
  64. 2015 - 2016
    MemberClinical Research Advisory Committee, Department of Pediatrics, The University of Texas MD Anderson Cancer Center
  65. 2015
    Co-Chair of Conference/SymposiaPediatric Neuro-Oncology Basic and Translational Research Conference, Teratoid Rhabdoid Tumor Session
  66. 2015
    Scientific CommitteePediatric Neuro-Oncology Basic and Translational Research Conference
  67. 2015
    MemberSociety of Neuro-Oncology (SNO)
  68. 2015
    Grant ReviewerLate Phase Study, Clinical Trials Awards and Advisory Committee, Cancer Research UK
  69. 2015 - present
    MemberUniversity of Texas MD Anderson Cancer Center, Clinical Trials Review, Clinical Research Advisory Committee
  70. 2014 - 2016
    Vice ChairGrand Rounds, Department of Pediatrics, The University of Texas MD Anderson Cancer Center
  71. 2014
    ChairPediatric Neuro-Oncology Symposium, The University of Texas MD Anderson Cancer Center
  72. 2014
    Chair of Conference/SymposiaPediatric Neuro-Oncology Symposium, The University of Texas MD Anderson Cancer Center
  73. 2013 - 2015
    MemberGraduate Medical Education Committee, The University of Texas MD Anderson Cancer Center
  74. 2013 - present
    MemberPosterior Fossa Society
  75. 2013 - present
    MemberTexas Oklahoma Pediatric Neuro-Oncology Consortium (TOPNOC)
  76. 2012 - 2021
    CoordinatorPediatric Neuro-Oncology Tumor Board, The University of Texas MD Anderson Cancer Center
  77. 2012
    NIH MemberHigh Impact Clinical Trial Program, Ontario Institute for Cancer Research
  78. 2011 - 2013
    MemberClinical Research Committee, The University of Texas MD Anderson Cancer Center
  79. 2011 - present
    MemberPediatric Oncology Experimental Therapeutics Investigators Consortium
  80. 2011 - present
    MemberHarris County Medical Society
  81. 2010
    Steering Committee MemberChildren's Center for Cancer and Research
  82. 2010 - present
    CNS Committee MemberChildren's Oncology Group
  83. 2010 - present
    Life MemberIndian Society of Neuro-oncology
  84. 2006 - present
    MemberAmerican Academy of Pediatrics
  85. 2003
    Chair of Conference/SymposiaPediatric Brain Tumors, International Conference of the World Federation of Neurosurgery (WFNS) - Tumor Section
  86. 2003 - present
    MemberAmerican Society of Pediatric Hematology/Oncology
  87. 2003 - present
    MemberChildren's Oncology Group
  88. 2003 - present
    Associate MemberSociety for Neuro-Oncology
  89. 2000
    MemberIndian Academy of Pediatrics

Publications